Status:

COMPLETED

Stenting of the Superficial Femoral and/or Proximal Popliteal Artery Project

Lead Sponsor:

Boston Scientific Corporation

Conditions:

Atherosclerosis of Native Arteries of the Extremities

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

To determine whether the Boston Scientific nitinol drug-eluting stent shows acceptable performance at 9 months when treating Superficial Femoral (SFA) and/or Proximal Popliteal Artery (PPA) lesions.

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Subjects age 18 and older
  • Subject (or Legal Guardian if applicable) has signed the consent form and is willing and able to provide consent before any study-specific tests or procedures are performed and agrees to attend all required follow-up visits
  • Chronic, symptomatic lower limb ischemia defined as Rutherford categories 2, 3 or 4
  • Stenotic, restenotic (from angioplasty only, previous treatment with drug coated balloon is not allowed) or occlusive lesion(s) located in the native superficial femoral artery or proximal popliteal artery:
  • Degree of stenosis ≥70% by visual angiographic assessment
  • Vessel diameter ≥ 4 and ≤ 6mm
  • Total lesion length (or series of lesions) ≥30 mm and ≤110 mm
  • (Note: tandem lesions may be treated, provided that the tandem lesion segment can be covered with only one stent)
  • Target lesion located at least three centimeters above the inferior edge of the femur
  • Patent infrapopliteal and popliteal artery, i.e., single vessel runoff or better with at least one of three vessels patent (\<50% stenosis) to the ankle or foot

Exclusion

    Key Trial Info

    Start Date :

    August 23 2013

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    February 20 2017

    Estimated Enrollment :

    57 Patients enrolled

    Trial Details

    Trial ID

    NCT01820637

    Start Date

    August 23 2013

    End Date

    February 20 2017

    Last Update

    March 22 2019

    Active Locations (13)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 4 (13 locations)

    1

    Royal Prince Alfred Hospital

    Camperdown, Australia

    2

    Prince of Wales Hospital

    Randwick, Australia

    3

    Allgemeines Krankenhaus AKH

    Vienna, Austria, Austria

    4

    AZ Sint-Blasius

    Dendermonde, Belgium, 9200